As fall COVID-19 surge looms, is it worth waiting for an Omicron-tailored vaccine? – CTV
Aug. 22, 2022
Anticipation is mounting for Canada to approve an updated version of the COVID-19 vaccine as fall threatens to usher in a new wave of infections.
Earlier this week, British regulators became the first in the world to authorize Moderna’s bivalent vaccine, which protects against both the original strain of the novel coronavirus and the Omicron BA.1 subvariant.
Health Canada is currently reviewing bivalent booster candidates from Moderna and Pfizer-BioNTech, which leaves some Canadians debating whether to wait for the revamped shots or go for a booster now.
With viral circulation projected to pick up as the season changes, some provinces are encouraging people to get a booster of the approved version of the vaccine. For many people, that would mean a fourth or fifth dose of the original formula.
